Jiang-Kun Liu

TL;DR: In this article , a review of the potential agents and nanoparticles that induce or inhibit RCD pathways and their therapeutic effects on cancer based on evidence from in vivo and in vitro studies and reports clinical trials in which RCD inducers have been evaluated as treatments for cancer patients.

TL;DR: The data suggest the presence of a stem-like cell population in human fibrosarcoma tumors, which provides more evidence for the cancer stem cell hypothesis and assistance in designing new therapeutic strategies against human fibrous tissue tumors.

TL;DR: A comprehensive understanding of the signaling cascades in CAFs might help us better understand the roles of CAFs and the tumor microenvironment in cancer progression and may facilitate the development of more efficient and safer stroma-targeted cancer therapies as discussed by the authors .

TL;DR: Wang et al. as mentioned in this paper used consensus clustering algorithm to identify two remarkably different subtypes, and a feasible risk stratification method was established to accurately estimate prognosis and the efficacy of immune therapy and chemotherapy.

TL;DR: Wang et al. as mentioned in this paper used consensus clustering algorithm to identify two remarkably different subtypes, and a feasible risk stratification method was established to accurately estimate prognosis and the efficacy of immune therapy and chemotherapy.